Compare BWFG & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWFG | CTKB |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.4M | 541.1M |
| IPO Year | 2014 | 2021 |
| Metric | BWFG | CTKB |
|---|---|---|
| Price | $64.67 | $4.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $55.00 | $5.63 |
| AVG Volume (30 Days) | 44.7K | ★ 831.2K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | $2,826,000.00 | ★ $193,015,000.00 |
| Revenue This Year | $17.64 | $5.42 |
| Revenue Next Year | $6.21 | $7.03 |
| P/E Ratio | $22.19 | ★ N/A |
| Revenue Growth | ★ 43.96 | 17.67 |
| 52 Week Low | $40.45 | $3.28 |
| 52 Week High | $69.59 | $6.18 |
| Indicator | BWFG | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 51.94 |
| Support Level | $45.62 | $4.17 |
| Resistance Level | $69.41 | $4.70 |
| Average True Range (ATR) | 1.67 | 0.23 |
| MACD | -0.51 | -0.00 |
| Stochastic Oscillator | 22.41 | 53.49 |
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.